BUZZ - With the approval of single stock perpetual futures and a market pullback, brokers see buying opportunities

November 4 - ** On Tuesday, the share prices of Cboe Global (CBOE.Z), CME Group (CME.O), Nasdaq (NDAQ.O), and Intercontinental Exchange (ICE.N) came under pressure after US regulators (link) cleared the way for single stock perpetual futures (link) to be traded as securities futures products in the United States.

** TD Cowen believes the current weakness provides a buying opportunity for Cboe, Nasdaq, and CME.

** Piper Sandler stated that this move is positive for derivatives trading platforms that wish to introduce crypto-related products domestically, and is also an important step for challenger trading platforms.

** "We believe this is less a direct threat to traditional exchange equities and options businesses and more an opportunity to bring a new wave of risk-seeking retail traders into the US stock market," said Piper Sandler's analyst team led by Patrick Moley.

** Perpetual futures are derivative products that never expire and do not require rolling over, allowing traders to hold positions indefinitely.

** A group backed by Cboe and Citadel Securities filed a federal lawsuit on Tuesday aiming to stop the US Commodity Futures Trading Commission (CFTC) from approving single stock perpetual futures.

(To facilitate non-native English speakers, Reuters has automated the translation of its reports into several other languages. As automated translations may contain errors or lack necessary context, Reuters does not guarantee the accuracy of the automated translation texts, which are provided solely for the convenience of readers. Reuters accepts no liability for any damage or loss arising from the use of automated translation functions.)